Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anette Lampert

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Drug Safety|April 18, 2022
Lack of Evidence for Blood Pressure Effects of Caffeine Added to IbuprofenAnette Lampert, Robert Lange, Thomas Weiser
Plos One|January 7, 2016
Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional AnalysisAnette Lampert, Georg F Hoffmann, Markus Ries
Journal of Patient Safety|January 12, 2016
Reasons for Drug Administration Problems and Perceived Needs for Assistance of Patients, Family Caregivers, and Nurses: A Qualitative StudyAnette Lampert, Walter E Haefeli, Hanna M Seidling
Pain and Therapy|January 9, 2020
A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Lysinate in Comparison to Ibuprofen Acid for Acute Postoperative Dental PainJán Kyselovič, Eva Koscova, Anette Lampert, et al.
Patient Education and Counseling|September 20, 2014
Do you have any questions about your medication?Anette Lampert, Walter E Haefeli, Hanna M Seidling
Deutsche Medizinische Wochenschrift (1946)|March 6, 2019
[Information Gaps in Package Inserts Cause Insufficient Patient Information on Correct Handling of Transdermal Patches]Anette Lampert, Walter E Haefeli, Hanna M Seidling
The Oncologist|March 30, 2016
Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional AnalysisClemens Stockklausner, Anette Lampert, Georg F Hoffmann, et al.
Orphanet Journal of Rare Diseases|May 14, 2016
Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug actThomas Lutz, Anette Lampert, Georg F Hoffmann, et al.
Expert Opinion on Drug Safety|June 13, 2014
A systematic review of medication administration errors with transdermal patchesAnette Lampert, Jasmin Seiberth, Walter E Haefeli, et al.
Plos One|February 22, 2019
Improving eye-drop administration skills of patients - A multicenter parallel-group cluster-randomized controlled trialAnette Lampert, Thomas Bruckner, Walter E Haefeli, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Drug Safety|April 18, 2022
Lack of Evidence for Blood Pressure Effects of Caffeine Added to IbuprofenAnette Lampert, Robert Lange, Thomas Weiser
Plos One|January 7, 2016
Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional AnalysisAnette Lampert, Georg F Hoffmann, Markus Ries
Journal of Patient Safety|January 12, 2016
Reasons for Drug Administration Problems and Perceived Needs for Assistance of Patients, Family Caregivers, and Nurses: A Qualitative StudyAnette Lampert, Walter E Haefeli, Hanna M Seidling
Pain and Therapy|January 9, 2020
A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Lysinate in Comparison to Ibuprofen Acid for Acute Postoperative Dental PainJán Kyselovič, Eva Koscova, Anette Lampert, et al.
Patient Education and Counseling|September 20, 2014
Do you have any questions about your medication?Anette Lampert, Walter E Haefeli, Hanna M Seidling
Deutsche Medizinische Wochenschrift (1946)|March 6, 2019
[Information Gaps in Package Inserts Cause Insufficient Patient Information on Correct Handling of Transdermal Patches]Anette Lampert, Walter E Haefeli, Hanna M Seidling
The Oncologist|March 30, 2016
Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional AnalysisClemens Stockklausner, Anette Lampert, Georg F Hoffmann, et al.
Orphanet Journal of Rare Diseases|May 14, 2016
Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug actThomas Lutz, Anette Lampert, Georg F Hoffmann, et al.
Expert Opinion on Drug Safety|June 13, 2014
A systematic review of medication administration errors with transdermal patchesAnette Lampert, Jasmin Seiberth, Walter E Haefeli, et al.
Plos One|February 22, 2019
Improving eye-drop administration skills of patients - A multicenter parallel-group cluster-randomized controlled trialAnette Lampert, Thomas Bruckner, Walter E Haefeli, et al.
Pageof 4